Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Incidental Gallbladder Cancer: Permission to Operate.

Erdem S, White RR.

Ann Surg Oncol. 2019 Nov 13. doi: 10.1245/s10434-019-08080-6. [Epub ahead of print] No abstract available.

PMID:
31722073
2.

Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model.

Narayanan JSS, Ray P, Hayashi T, Whisenant TC, Vicente D, Carson DA, Miller AM, Schoenberger SP, White RR.

Cancer Immunol Res. 2019 Oct;7(10):1714-1726. doi: 10.1158/2326-6066.CIR-19-0101. Epub 2019 Aug 13.

PMID:
31409607
3.

A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry.

Holland MM, Bhutiani N, Kruse EJ, Weiss MJ, Christein JD, White RR, Huang KW, Martin RCG 2nd.

HPB (Oxford). 2019 Aug;21(8):1024-1031. doi: 10.1016/j.hpb.2018.12.004. Epub 2019 Feb 5.

PMID:
30737097
4.

Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis.

Naqvi I, Gunaratne R, McDade JE, Moreno A, Rempel RE, Rouse DC, Herrera SG, Pisetsky DS, Lee J, White RR, Sullenger BA.

Mol Ther. 2018 Apr 4;26(4):1020-1031. doi: 10.1016/j.ymthe.2018.02.018. Epub 2018 Feb 23.

5.

Clinical Management: Resectable Disease.

White RR, Lowy AM.

Cancer J. 2017 Nov/Dec;23(6):343-349. doi: 10.1097/PPO.0000000000000291. Review.

PMID:
29189330
6.

Cell-SELEX Identifies a "Sticky" RNA Aptamer Sequence.

Ray P, White RR.

J Nucleic Acids. 2017;2017:4943072. doi: 10.1155/2017/4943072. Epub 2017 Jan 17.

7.

Aptamers as Therapeutics.

Nimjee SM, White RR, Becker RC, Sullenger BA.

Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:61-79. doi: 10.1146/annurev-pharmtox-010716-104558. Review.

8.

TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.

Hesler RA, Huang JJ, Starr MD, Treboschi VM, Bernanke AG, Nixon AB, McCall SJ, White RR, Blobe GC.

Carcinogenesis. 2016 Nov 1;37(11):1041-1051. doi: 10.1093/carcin/bgw093.

9.

In Vivo Selection Against Human Colorectal Cancer Xenografts Identifies an Aptamer That Targets RNA Helicase Protein DHX9.

Mi J, Ray P, Liu J, Kuan CT, Xu J, Hsu D, Sullenger BA, White RR, Clary BM.

Mol Ther Nucleic Acids. 2016 Apr 26;5:e315. doi: 10.1038/mtna.2016.27.

10.

A standardized care plan is associated with shorter hospital length of stay in patients undergoing pancreaticoduodenectomy.

Nussbaum DP, Penne K, Stinnett SS, Speicher PJ, Cocieru A, Blazer DG 3rd, Zani S, Clary BM, Tyler DS, White RR.

J Surg Res. 2015 Jan;193(1):237-45. doi: 10.1016/j.jss.2014.06.036. Epub 2014 Jun 26.

PMID:
25062813
11.

Feeding jejunostomy tube placement in patients undergoing pancreaticoduodenectomy: an ongoing dilemma.

Nussbaum DP, Zani S, Penne K, Speicher PJ, Stinnett SS, Clary BM, White RR, Tyler DS, Blazer DG 3rd.

J Gastrointest Surg. 2014 Oct;18(10):1752-9. doi: 10.1007/s11605-014-2581-6. Epub 2014 Jun 25.

PMID:
24961442
12.

Defining the learning curve for team-based laparoscopic pancreaticoduodenectomy.

Speicher PJ, Nussbaum DP, White RR, Zani S, Mosca PJ, Blazer DG 3rd, Clary BM, Pappas TN, Tyler DS, Perez A.

Ann Surg Oncol. 2014 Nov;21(12):4014-9. doi: 10.1245/s10434-014-3839-7. Epub 2014 Jun 13.

PMID:
24923222
13.

Wound classification reporting in HPB surgery: can a single word change public perception of institutional performance?

Speicher PJ, Nussbaum DP, Scarborough JE, Zani S, White RR, Blazer DG 3rd, Mantyh CR, Tyler DS, Clary BM.

HPB (Oxford). 2014 Dec;16(12):1068-73. doi: 10.1111/hpb.12275. Epub 2014 May 23.

14.

Groove Pancreatitis: Four Cases from a Single Center and Brief Review of the Literature.

Black TP, Guy CD, White RR, Obando J, Burbridge RA.

ACG Case Rep J. 2014 Apr 4;1(3):154-7. doi: 10.14309/crj.2014.35. eCollection 2014 Apr.

15.

The role of clinical care pathways: an experience with distal pancreatectomy.

Nussbaum DP, Penne K, Speicher PJ, Stinnett SS, Perez A, White RR, Clary BM, Tyler DS, Blazer DG 3rd.

J Surg Res. 2014 Jul;190(1):64-71. doi: 10.1016/j.jss.2014.02.026. Epub 2014 Feb 24.

PMID:
24666986
16.

Hepatic resection for hepatocellular carcinoma: do contemporary morbidity and mortality rates demand a transition to ablation as first-line treatment?

Li GZ, Speicher PJ, Lidsky ME, Darrabie MD, Scarborough JE, White RR, Turley RS, Clary BM.

J Am Coll Surg. 2014 Apr;218(4):827-34. doi: 10.1016/j.jamcollsurg.2013.12.036. Epub 2014 Jan 10.

PMID:
24655879
17.

Neoadjuvant chemotherapy for localized pancreatic cancer: too little or too long?

White RR, Evans DB.

Ann Surg Oncol. 2014 May;21(5):1508-9. doi: 10.1245/s10434-014-3490-3. Epub 2014 Jan 23. No abstract available.

PMID:
24452411
18.

Further characterization of the target of a potential aptamer biomarker for pancreatic cancer: cyclophilin B and its posttranslational modifications.

Ray P, Sullenger BA, White RR.

Nucleic Acid Ther. 2013 Dec;23(6):435-42. doi: 10.1089/nat.2013.0439. Epub 2013 Oct 23.

19.

Trends in racial disparities in pancreatic cancer surgery.

Shah A, Chao KS, Ostbye T, Castleberry AW, Pietrobon R, Gloor B, Clary BM, White RR, Worni M.

J Gastrointest Surg. 2013 Nov;17(11):1897-906. doi: 10.1007/s11605-013-2304-4. Epub 2013 Sep 4.

PMID:
24002757
20.

Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.

Worni M, Guller U, White RR, Castleberry AW, Pietrobon R, Cerny T, Gloor B, Koeberle D.

Pancreas. 2013 Oct;42(7):1157-63. doi: 10.1097/MPA.0b013e318291fbc5.

PMID:
23867367

Supplemental Content

Loading ...
Support Center